A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

(2021) Annette B. Vogel et al.   NATURE

Antibodies and Vaccines Target RBD of SARS-CoV-2

(2021) Long Min et al.   Frontiers in Molecular Biosciences

New SARS-like virus in China triggers alarm

(2020) Jon Cohen et al.   SCIENCE

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

(2020) Jun Lan et al.   NATURE

Rapid COVID-19 vaccine development

(2020) Barney S. Graham   SCIENCE

Immunogenicity of a DNA vaccine candidate for COVID-19

(2020) Trevor R. F. Smith et al.   Nature Communications

COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury

(2020) Zhongfang Wang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Thermostable mRNA Vaccine against COVID-19

(2020) Na-Na Zhang et al.   CELL

COVID-19 vaccine development pipeline gears up

(2020) Asher Mullard   LANCET

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

(2020) Jingyun Yang et al.   NATURE

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

(2020) Kizzmekia S. Corbett et al.   NATURE

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

(2020) Neeltje van Doremalen et al.   NATURE

Animal and translational models of SARS-CoV-2 infection and COVID-19

(2020) M. D. Johansen et al.   Mucosal Immunology

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

(2020) Ugur Sahin et al.   NATURE

Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

(2020) Jennifer R. Habel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein

(2020) Daisuke Muraoka et al.   VACCINE

Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease

(2020) Joseph W. Golden et al.   JCI Insight

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

(2020) Fatai S. Oladunni et al.   Nature Communications

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans?

(2017) Hana Golding et al.   Cold Spring Harbor Perspectives in Biology

Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection

(2014) R. Channappanavar et al.   JOURNAL OF VIROLOGY

MHC–peptide tetramers for the analysis of antigen-specific T cells

(2010) Stuart Sims et al.   Expert Review of Vaccines

CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein

(2010) Kai Zhao et al.   VACCINE

CD8+ T cell efficacy in vaccination and disease

(2008) Victor Appay et al.   NATURE MEDICINE